VEGF-A mediates its biological response through VEGFR2, therefore, it is believed that the protein tyrosine kinase VEGFR2 is a potential target for anti-cancer therapy, as it acts as a medium for VEGF-A to exert its biological activities [84]. Here, VEGFA is linked to cancer.